Suggesting that the standard 10-year age gap screening rule might not be as beneficial as previously assumed, researchers have indicated that women with relatives diagnosed at younger ages should consider different screening criteria.

In a study cohort that included a total of 2,674,051 screening mammograms, these factors were found to result in the highest recall rates. 

While FIF is an extremely rare condition—occurring in about one in 500,000 births—it is even more rare in triplet pregnancies.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

Almost half of U.S. women covered by or eligible for Medicare have not been screened for breast cancer for at least three years, according to a study just out from the Radiology Business Management Association.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

ACR TI-RADS has previously been shown to lack sensitivity for distinguishing between benign and malignant thyroid lesions in pediatric patients.

Digitized informed patient consent prior to contrast-enhanced CT exams has significant advantages over traditional paper consent forms, but it also has the unfortunate effect of leaving some of the most vulnerable patients behind.